iqvia glp-1 prescriptions semaglutide tirzepatide q3 2024 us iqvia prescriptions q3 2024 semaglutide tirzepatide Prescriptions Are Up, Health Services Utilization Down, and GLP-1s Are a Major Growth Driver: IQVIA's 2024 Update-bsmoothhr 2024: The obesity market's inflection

US$ 25.74

★★★★★ 5.0 (28 reviews)

US$ 20.00

★★★★★ 4.4 (26 reviews)

US$ 28.34

★★★★★ 4.0 (26 reviews)

US$ 29.26

★★★★★ 4.8 (7 reviews)

US$ 20.63

★★★★★ 4.8 (6 reviews)

US$ 26.12

★★★★★ 4.8 (25 reviews)

US$ 25.03

★★★★★ 4.1 (10 reviews)

US$ 24.46

★★★★★ 4.6 (22 reviews)

US$ 24.91

★★★★★ 4.0 (14 reviews)

US$ 24.24

★★★★★ 4.2 (20 reviews)

US$ 23.65

★★★★★ 4.4 (28 reviews)

US$ 21.70

★★★★★ 4.7 (18 reviews)

US$ 25.23

★★★★★ 5.0 (14 reviews)

US$ 20.05

★★★★★ 4.1 (24 reviews)

US$ 24.53

★★★★★ 4.4 (8 reviews)

US$ 20.97

★★★★★ 4.1 (19 reviews)

US$ 20.59

★★★★★ 4.1 (16 reviews)

US$ 28.88

★★★★★ 4.5 (24 reviews)

US$ 24.14

★★★★★ 4.6 (24 reviews)

US$ 22.42

★★★★★ 5.0 (6 reviews)